🇺🇸

Broad Market

US SEC Filing Intelligence · 614 digests

New to these filings? Learn what an 8-K is

· daily

US Material Events SEC 8-K Filings — October 09, 2026

Across the 50 filings dated October 9, 2026, the dominant themes are capital raising and balance-sheet management (ATM programs, registered directs, a $575M convertible from Vaxcyte, a $700M Atmos Energy senior note, Gray Media's refinancing and Term Loan G add-on), executive and director turnover (Avient CEO change, Quantum CFO termination, Standard Motor CFO exit, Victoria's Secret and Mitek senior departures), and corporate restructuring (MSG Sports Rangers spin-off, Evernorth/Armada business combination, Ranger Energy's $27.5M asset acquisition). Filings in the set largely lack quantified period-over-period results, so portfolio-level growth and margin trends cannot be computed reliably; the quantitative signal comes mainly from Atmos, Ashford, Alpine, Gray Media and Dentsply covenant data. Stress indicators cluster in micro-cap and SPAC names (Verde Resources auditor change with material weaknesses, Universal Safety's note financing exceeding its stated cap, Sunshine Biopharma's dilutive best-efforts deal) and in Dentsply's temporary covenant relief. Positive refinancing outcomes at Gray Media, McGraw Hill and Ares Commercial stand in contrast. The most market-moving items are the Evernorth/XRP business combination with its $6.9M unrecorded impairment exposure, Dentsply's covenant amendments, and Quantum's CFO change alongside a guidance reaffirmation.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — October 09, 2026

Across the 50 filings for the 'Global High Priority Market Events' stream dated 2026-10-09, the dominant theme is restructuring and control activity in Indian mid-caps and US small-caps: scheme-of-merger approvals (Lodha/National Standard/Roselabs), change-of-control events (Baba Arts, Skybridge), and multiple SPAC and micro-cap delisting or listing-compliance notices (Vestand, Alaunos, Better Home & Finance, Armada II, Plum IV, Launch Two). The most material single development is the Vireo Growth/Planet 13 S-4 merger (materiality 9/10), with the mixed picture of a fairness-opined cannabis combination. The most severe credit event is MTNL's default to seven public-sector banks totaling Rs 9,732 crore in current defaults against Rs 37,553 crore of total indebtedness, with all listed lenders now classified as NPA. Quantitative period-over-period data is sparse in this batch: most filings are procedural, so comparisons were drawn only where the disclosures supplied them (e.g., Triveni/TPTL, Hubtown/RTPL, ASI/Lloyds, Ashford pro forma). Several Indian approvals carried notable minority dissent or low public participation, which warrants scrutiny in the schemes. Overall the stream reads as a late-stage restructuring and delisting environment rather than a broad M&A wave.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — October 09, 2026

Today's filing set is dominated by M&A and capital-markets activity, with several large transactions in motion (C.H. Robinson/RXO, NextEra/Dominion, Medtronic's MiniMed separation, DSG's LKCM-backed going-private, First Bancorp/First Carolina, and GigCapital8/Quantisimo). Governance and shareholder-vote items are heavy, including multiple SPAC extensions and redemption windows, a SPAC-style deal structure with thin disclosure, and a DEF 14A cluster for Solidion. Financial performance data is sparse in most filings, so period-over-period evidence is limited, but the few quantified results point to a bifurcated picture: Huineng swung to nine-month profitability on a revenue surge while still losing money in the quarter, City Therapeutics' loss widened sharply, and OMA's September passenger traffic fell 4.8% YoY with domestic traffic down 5.9%. Healthcare and biotech signals were mixed to positive, led by Humana's Stars result that exceeds its Top Quartile goal and affirmed FY2026 Adjusted EPS of at least $9.00. A large cluster of 13F-HR filings (Shira Ridge, Ledgewood, DLK, Retireful, TLWM, Sunburst, Pioneer, M.E. Allison) reports ETF-heavy, passive-leaning portfolios with no prior-period comparisons, so they provide holdings context rather than directional signal. Overall, the day's market implications centre on deal-completion risk, shareholder-vote outcomes, and SPAC redemption dynamics rather than broad earnings momentum.

14 high priority 36 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — October 09, 2026

The overnight SEC stream for 2026-10-08 to 2026-10-09 is dominated by routine Form 4 equity-award and tax-withholding filings (roughly 25 of 50), with a concentrated cluster at BioLife Solutions showing both large tax withholdings and director share dispositions. Substantive corporate developments are fewer: XWELL's airport-business sale proxy (base price $13.0M with an unquantified arbitration exposure), Distribution Solutions Group's upsized $800M 10% notes tied to a $35.00/share LKCM Headwater buyout, Gossamer Bio's 13D/A correction ahead of an October 27 special meeting, and the K&F Growth II SPAC extension vote with trust value near $10.716 per share versus a $10.68 market price. Several large-cap strategic filings (NextEra/Dominion, Medtronic/MiniMed exchange offer) are Rule 425 communications that reference prospectuses or S-4s not included in the text, so no valuation or exchange-ratio data can be verified. Enriched period-over-period, guidance, and transaction-valuation fields are largely absent across the set, which limits quantitative trend synthesis; most conclusions rest on the disclosed event data rather than on YoY or QoQ comparisons. Portfolio-level theme: heavy SPAC and shareholder-vote activity, with insider flows concentrated in governance-driven grants and withholdings rather than open-market conviction signals.

36 high priority 14 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — October 08, 2026

The 50-filing Material Events Monitor for 2026-10-08 is dominated by large M&A and capital-markets activity, with a clear split between transformational deals (Crescent Energy's $3.85B Eagle Ford purchase, Viatris' $1.65B Pacira acquisition, Hess Midstream's Chevron DJ Basin transaction, Drilling Tools' Saltire/Foxley deal) and a long tail of governance housekeeping (certificate eliminations, director retirements, officer departures). Period-over-period data is sparse in the supplied summaries, so trend analysis is largely qualitative: leverage and liquidity management is widespread (TETRA amendment, GEO refinancing, Hercules $400M notes, Bain $350M notes, PRA $400M offering), and several small-cap issuers rely on dilutive or related-party financing (Atrium, FibroBiologics, Tivic/Valion, Silver Bow). Management succession is a notable recurring theme across the set (General Dynamics, AngioDynamics, Henry Schein, MFA Financial, Byline, Gartner, Vontier, Kirby), suggesting planned generational transitions rather than distress in most cases. Insider activity is limited to XWELL's sub-level RSA repurchases and retention awards at Payoneer, so conviction signals are thin. Overall the day skews toward positive, cash-generative strategic moves at larger issuers and dilution/governance risk at micro-caps.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — October 08, 2026

The 42 filings for the 'Global High Priority Market Events' stream are dominated by corporate-restructuring and capital-markets events rather than classic bankruptcies. Several Indian insolvency and CIRP matters (Astron Paper, SKIL, BGR Energy, Polycab, Meghmani, Arisinfra, KSS) sit alongside a dense cluster of SPAC milestones (IPOs, extensions, S-4s, business combinations) and US tender offers and Nasdaq delisting notices. The enriched data available in these filings is thin for most items: the narrative provides few period-over-period figures, forward guidance, or insider activity, so most quantitative synthesis is limited to the handful of filings that disclose deal values or financial metrics. The most material developments are the Polycab CIRP petition appeal (9/10), the Hari Govind/Popees share-swap acquisition with ₹511 crore consideration (9/10), the Semilux and Smart Powerr Nasdaq delistings, and the Medtronic/MiniMed exchange offer. Insolvency and delisting events cluster as negative signals, while SPAC and tender-offer activity carries mostly neutral read-throughs pending closings. Insider-activity and capital-allocation fields are largely absent from the supplied filings, which limits conviction-level conclusions.

42 high priority 42 total filings
· daily

US SEC Filings Daily Market Digest — October 08, 2026

Today's stream of 50 SEC filings for October 8, 2026 is dominated by routine foreign private issuer 6-Ks, monthly regulatory returns, and small-cap SPAC and capital-structure housekeeping, with only a handful of market-moving disclosures. The clearest fundamental signals come from large-cap earnings and operating data: PepsiCo delivered a strong Q3 top line (+5.6% net revenue, +17% EPS) but cut full-year core EPS guidance sharply to +2.5-3.5% on input-cost inflation, while TSMC's September revenue rose 54.6% YoY (nine-month revenue +41.1%) despite a 0.6% sequential dip, and ChipMOS posted Q3 revenue up 36.7% YoY with only +0.2% month-over-month momentum in September. Deal activity is concentrated in Drilling Tools International's ~$81M cash plus 17.4M-share acquisition of Saltire/Foxley, which would lift Eastern Hemisphere exposure from ~18% to ~40% of pro forma revenue. Balance-sheet stress shows up in SolarMax (cash down 72.9% since December while receivables rose 37.2%) and in New ERA's $116M letter-of-credit funding that required cash collateral and warrant issuance. Insider flow is almost entirely small-lot purchases at TSMC, which carry low economic weight but signal internal confidence. Overall the day's read is mixed: strong year-over-year growth at mega-cap and Asian semis versus margin pressure and liquidity strain at smaller, financing-dependent issuers.

31 high priority 19 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — October 08, 2026

Overnight SEC filings were dominated by insider activity, with a clear cluster of director equity awards at Wave Life Sciences (WLES) and routine tax-related transactions at Coherent Corp. and Streamex Corp. No major 10-K/10-Q earnings releases, M&A, or guidance updates were filed overnight. The most notable signal is the coordinated Wave Life Sciences director compensation package (10 directors each receiving restricted stock and options), suggesting management alignment ahead of upcoming catalysts. Streamex Corp. shows insider selling at low prices, a mildly bearish signal. Overall, the tape is quiet with no material fundamental news.

34 high priority 16 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — October 07, 2026

Today's filings reveal a market actively reallocating capital through M&A, spin-offs, and refinancings. Notable transactions include First Digital's $250M SPAC merger, Healthcare Services Group's $93.5M acquisition of NEXDINE, and Ultragenyx's $210M PRV sale. Several companies are bolstering liquidity or reducing debt costs, including Magnite's third debt repricing and BKV's $1.2B power equipment contract. Leadership transitions are widespread, with new CFOs at FuelCell Energy, Ocean Power, and Tessera, and a major C-suite restructuring at lululemon. Financial performance is mixed: Richardson Electronics shows strong growth (sales +18.9% YoY, net income +112.6%), while Greenlane's subsidiaries are in liquidation. The SPAC sector is active with new IPOs and business combinations, but some deals face tight deadlines and execution risks.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — October 07, 2026

This digest covers 41 filings, dominated by severe distress signals across multiple sectors. The most critical theme is a wave of insolvencies and delistings, with 8 companies in active CIRP (Corporate Insolvency Resolution Process) and 4 receiving final delisting notices from Nasdaq, including NUSATRIP, Sangamo Therapeutics, and Aditxt. A significant regulatory enforcement action was taken by SEBI against Rashi Equisearch. On the M&A front, activity is mixed: a major SPAC merger values First Digital at $250M, while Adani Energy Solutions pursues strategic infrastructure growth. Period-over-period data reveals stark contrasts; Richardson Electronics posted a 112.6% surge in net income, while Greenlane Holdings' subsidiaries were liquidated, and Abans Financial's subsidiary saw a 41% revenue decline. The overall sentiment is heavily bearish, with a high concentration of default and insolvency events creating a 'watch list' of companies facing existential threats. The most actionable intelligence lies in the contrast between fundamentally strong companies facing temporary regulatory hurdles (like Polycab India) and those with terminal business models (like Greenlane). The SPAC market shows signs of life but with significant execution risk, as seen in the tight deadlines for Charlton Aria Acquisition Corp and Launch Two Acquisition Corp.

41 high priority 41 total filings
· daily

US SEC Filings Daily Market Digest — October 07, 2026

The October 7, 2026 filing batch reveals a market bifurcated between high-growth consumer lending and distressed micro-caps. SPAC activity dominates with three major business combinations targeting critical minerals (Nth Cycle), stablecoins (First Digital), and national security tech (REDLattice), collectively valued at over $835M. Period-over-period comparisons show stark contrasts: Figure Technology's consumer loan volume surged 107% YoY while Odyssey Marine's revenue collapsed 51% and NUSATRIP faces delisting. Insider ownership filings highlight Fidelity's 10.7% Illumina stake and Coastlands' 6.67% OnKure position. Forward-looking guidance from Rezolve AI ($360M revenue target) and Robo.AI ($600M FY2026) signal growth ambitions but are tempered by cash burn warnings. The delisting of NUSATRIP and voluntary withdrawal of Viking Acquisition underscore ongoing market discipline for non-performing entities.

16 high priority 34 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — October 07, 2026

Overnight filings reveal a mixed picture for US markets, headlined by a major SPAC deal in digital assets and a critical delisting. First Digital's $250M business combination with CSLM Digital Asset Acquisition Corp brings stablecoin exposure to Nasdaq, while NUSATRIP's imminent delisting serves as a stark warning on micro-cap risk. The most significant period-over-period trend comes from Costco, which reported a robust 10% YoY revenue growth to $297B, though gross margins saw slight compression. Conversely, Odyssey Marine Exploration's financials show a severe deterioration, with revenue halving and losses widening. Insider activity was largely neutral, dominated by routine stock awards and tax-withholding sales at MGM Resorts and Kenvue. A notable capital allocation move was the $61.8M equity investment in Gogoro, signaling confidence in the EV space. The most actionable intelligence centers on the First Digital SPAC, Costco's steady growth, and the risk flags around Odyssey Marine and NUSATRIP.

28 high priority 22 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — October 06, 2026

The October 6, 2026, filings reveal a market sharply bifurcated between aggressive corporate restructuring and significant financial distress. A dominant theme is large-scale refinancing and balance sheet repair, with AMC Entertainment ($3.97B), HighPeak Energy ($1.25B), and Sysco ($18.5B for an acquisition) executing transformative capital markets transactions. Simultaneously, a wave of governance upheaval and financial fragility is evident, highlighted by the boardroom coup at Better Home & Finance and the auditor resignation at Ludwig Enterprises. M&A activity is robust, with IES Holdings ($691M) and Clarivate ($600M) completing major deals, while the SPAC Oceanhawk Acquisition continues its search for a target. The quarter-end period saw a flurry of credit agreement amendments, suggesting companies are proactively managing liquidity. Overall, the data points to a market where well-capitalized firms are aggressively pursuing growth and debt reduction, while weaker entities are resorting to dilutive financing and facing existential risks.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — October 06, 2026

The 50 filings reveal a concentrated wave of Indian corporate insolvencies (8+ companies entering CIRP, including Spright Agro, TV Vision, and Sun Granite Export), signaling severe distress in small-cap industrials and real estate. Healthcare M&A consolidation is a key theme, with Krishna Institute of Medical Sciences (KIMS) executing four acquisitions totaling up to ₹135 Cr, though most targets are loss-making, indicating a long-term strategic play. Large-cap M&A dominates in the US: IES Holdings acquired DBM Global for ~$691M (its largest deal), and Clarivate sold its Life Sciences segment for $600M to sharpen focus. SPAC activity remains active with Tavia Acquisition Corp's sponsor change and Melar Acquisition Corp's business combination vote set for October 22. Delisting risks are rising: FibroGen and Virtuix received Nasdaq non-compliance notices, while Bed Bath & Beyond's warrants were finally delisted. Period-over-period trends show extreme revenue collapses (Visagar Polytex from ₹71,017 lakh to zero) and rapid growth in early-stage companies (Meesho's investee revenue grew 6x to ₹16 Cr but remains unprofitable). The overall sentiment is predominantly negative or neutral, with only a few positive signals from well-capitalized acquirers.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — October 06, 2026

The October 6, 2026, filing slate is dominated by a single mega-cap M&A event: C.H. Robinson's $5.8 billion acquisition of RXO, creating a $25 billion enterprise value logistics powerhouse with $300 million in projected synergies. This deal overshadows a day otherwise characterized by capital structure maneuvers, including AMC's $3.97 billion refinancing and HighPeak Energy's $1.25 billion restructuring. A notable negative outlier is Blaize Holdings, which slashed its full-year revenue guidance by over 50% to $32-36 million, signaling severe operational distress. Insider activity was sparse but included a significant $4.87 million purchase in Anteris Technologies by a 10% owner, a bullish signal. The day also featured a controlling stake acquisition in AGM Group Holdings and a concerning reverse stock split plan from DarkIris Inc., highlighting a bifurcated market where large-cap strategic moves contrast with micro-cap distress.

21 high priority 29 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — October 06, 2026

This overnight filing cycle reveals a bifurcated market with aggressive insider buying at **Accelevation Holdings Corp.** and **LENNAR CORP** (via Berkshire Hathaway) contrasting sharply with mass insider selling at **Strive, Inc.** and **Vista Energy**. The most significant capital market event is the $360M block sale by a 10% owner at **Accelevation**, immediately followed by insider director and CEO purchases at the same price point, signaling a potential floor. **Vylor Inc.** shows a massive insider equity acquisition event across its entire C-suite, suggesting a major equity restructuring or grant program. **Arbutus Biopharma** completed a $230M modified Dutch auction, with its largest shareholder maintaining proportional ownership. The **Strive, Inc.** insider selling is the most bearish signal of the batch, with the CEO, CFO, and CLO all liquidating significant positions simultaneously. No period-over-period financial comparisons or forward-looking guidance were available in these filings, as the batch is dominated by Form 4 insider transaction filings.

49 high priority 1 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — October 05, 2026

This Material Events Monitor digest covers 50 SEC filings from October 5, 2026, revealing a market dominated by significant M&A and capital restructuring activity. The most transformative deals include Schneider Electric's $22.6 billion all-cash acquisition of PTC Inc., Skyworks Solutions' combination with Qorvo, and The GEO Group's $950 million facility sale to the U.S. government. A clear sector theme is the aggressive consolidation in industrial software and semiconductor spaces, driven by synergies and scale. Capital allocation trends show a bifurcation: some companies like GEO Group are deploying sale proceeds into massive buyback programs, while others like Consensus Cloud Solutions are refinancing high-cost debt. Insider activity is limited but includes notable CFO departures at Insmed and Phillips 66, which carry medium materiality. Forward-looking data points to a rich catalyst calendar, with key earnings calls from Skyworks and Insmed in early November, and several high-value M&A transactions expected to close in late 2026 and 2027.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — October 05, 2026

This digest covers 50 filings from October 5, 2026, dominated by a wave of corporate restructurings, delistings, and M&A activity. The most critical developments include the Chapter 11 bankruptcy of Leslie's, Inc., the voluntary delisting of Dillard's, Inc. from the NYSE, and the completed mega-merger of Skyworks Solutions and Qorvo. A significant trend is the high volume of SPAC activity, with several business combinations progressing and one new IPO pricing, alongside multiple insolvency proceedings in the Indian market. Period-over-period data reveals mixed financial health, with Lincoln Bancorp showing a sharp swing to a net loss ahead of its merger, while Satiya Nutraceuticals (Marico subsidiary) demonstrates explosive revenue growth. The overall market implication is a bifurcated environment where strategic, value-creating transactions (GEO Group, Skyworks/Qorvo) coexist with financial distress and liquidity events (Leslie's, ESS Tech).

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — October 05, 2026

Today's filings reveal a market bifurcated between aggressive capital returns and operational distress. A significant capital allocation theme emerged, with ORIX Corp and Toyota Motor Corp collectively repurchasing over $1.5 billion in shares during September, signaling strong management confidence in their valuations. However, this contrasts sharply with severe operational disruptions at New Fortress Energy (Fast LNG unit offline) and a wave of governance red flags, including repeated failed annual meetings at Co-Diagnostics and Adial Pharmaceuticals due to Nasdaq listing delays. The SPAC sector remains active but fraught with risk, as three separate filings (Bold Eagle, Melar Acquisition, Tigerless Health) highlight liquidity pressures, redemption risks, and governance structures that heavily favor insiders. Period-over-period data from the banking sector shows mixed signals: Lincoln Bancorp's net loss widened to $13.19 million (vs. $1.2 million loss last year) due to a $15.7 million realized loss on securities, even as net interest income improved 4.2%. The most actionable intelligence centers on the $180 million Melar-Everli deal, which faces a matured $5.6 million loan, and the $43/share all-cash buyout of Bowman Consulting, offering a clear arbitrage opportunity.

17 high priority 33 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — October 05, 2026

The overnight filing batch (Oct 4-5, 2026) reveals a market bifurcated between aggressive capital returns and liquidity-driven distress. Major capital returns dominate: Toyota repurchased ~$1.0B in September (10.9% of its authorized buyback), ORIX deployed ~$139B yen (55.6% of its program), and Bradesco completed a $1.8B capital raise. Meanwhile, SPACs and micro-caps face existential risks: Bold Eagle, Spark I, and Melar all face redemption/liquidation pressures, while Tigerless Health's deal structure allows closure despite massive redemptions. Healthcare shows mixed signals: Novo Nordisk's FDA delay is facility-related (not efficacy), Jasper's Kira acquisition closed with a $132M PIPE, but Rallybio's merger with Avenzo carries high dilution risk. Insider activity is sparse but notable: PicoCELA executives returned 5M shares, and Curaleaf's CEO received a $15.4M RSU grant. Operational disruptions (New Fortress Energy's FLNG outage) and governance failures (Co-Diagnostics' repeated quorum failures) add to the risk landscape. Period-over-period data is limited, but Lincoln Bancorp's H1 2026 net loss of $13.19M (vs $1.2M loss in H1 2025) highlights the impact of realized losses on bank earnings.

17 high priority 33 medium 50 total filings